Journal of Molecular Neuroscience · 2022 · 15 citations · 27 references
MedicineOncologyRadiation OncologyHematologic OncologyNeuro-oncologyTumor MicroenvironmentBrain TumorsCancer BiomarkersCellular Responses To HypoxiaGlioblastomaMeningioma RadiotherapyTumor MarkersControl Group DesignGlioblastoma HypoxiaHypoxiaHypoxia ResponsesTumor Microenvironment Hypoxia
Hypoxia is a prevalent hallmark of many malignant neoplasms. The aim was to assess the serum hypoxia biomarkers HIF-1α, VEGF, osteopontin, erythropoietin, caveolin-1, GLUT-1, and LDH pre- and post-radiotherapy in patients with brain tumors. The study was conducted on 120 subjects were divided into two groups: group I: 40 healthy volunteers as control group. Group II: 80 brain tumor patients were subdivided into glioblastoma subgroup: 40 glioblastoma patients, meningioma subgroup: 40 malignant meningioma patients. Two venous blood samples were collected from every patient prior to and following RT and one sample from controls. Biomarkers were assayed by ELISA. In glioblastoma subgroup, HIF-1α, VEGF, and LDH were significantly increased after RT. On the contrary, these biomarkers were significantly decreased after RT in malignant meningioma subgroup. Osteopontin was significantly increased after RT in both subgroups. Regarding erythropoietin, it was significantly decreased in both subgroups when compared to before RT. Caveolin-1 showed a significant increase in glioblastoma subgroup after RT comparing to before RT. GLUT-1 was significantly increased after RT in both subgroups comparing to before RT. Association of significant elevation of hypoxia biomarkers either pre- or post-RT with aggressive tumor such as glioblastoma indicates that, they are markers of malignancy and may have a role in tumor development and progression.
27
Feng‐Ming Kong, Randall K. Ten Haken, Matthew J. Schipper et al. · JAMA Oncology · 2017 · 222 citations · Full text
Medicine, Nuclear Medicine, Oncology +14
Peddagangannagari Sreekanthreddy, Harish Srinivasan, Durairaj Mohan Kumar et al. · Cancer Epidemiology Biomarkers & Prevention · 2010 · 128 citations
Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation
Fei Zhao, Ming Jia, Yan Zhou et al. · Cancer Chemotherapy and Pharmacology · 2016 · 111 citations
Medicine, Cancer Biology, Oncology +14